Podcast thumbnail for Ophthalmology Reimbursed

Ophthalmology Reimbursed

Claim This Podcast

by Corcoran Consulting Group

5.0(2 reviews)
11 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇺🇸

Podcast Overview

<p>Ophthalmology Reimbursed discusses all things coding, reimbursement, auditing and education for the ophthalmic community. Since 1986, Corcoran Consulting Group has served thousands of physicians in ophthalmic and optometric practices in all 50 states.</p>

Language

🇺🇲

Publishing Since

10/7/2025

Reach the team behind Ophthalmology Reimbursed

Verified contact details for this show aren't on file yet — sign up to get notified when they land.

Recent Episodes

Episode thumbnail for What the 2026 CPT Panel Actions Mean for Ophthalmology

June 2, 2026

What the 2026 CPT Panel Actions Mean for Ophthalmology

The CPT Editorial Panel’s February and May 2026 Summary of Actions offers an early look at where coding and reimbursement are headed, and ophthalmology is clearly part of the conversation. In this episode, our consultants break down the ophthalmology-related proposals, accepted actions, withdrawn items, and emerging Category III codes discussed by the CPT Panel. Topics include adult goniotomy coding changes, intraocular drug delivery implants, subretinal prostheses, intracapsular magnificatio...

Episode thumbnail for From ASCRS 2026: New Frontiers in Eye Care (Part 3) – Featuring Alcon

May 4, 2026

From ASCRS 2026: New Frontiers in Eye Care (Part 3) – Featuring Alcon

In Part 3 of our ASCRS 2026 series, we explore photobiomodulation and its potential role in advancing eye care. We’re joined by Traci Brackett and Joshua Anderson from Alcon, who share their insights on this emerging therapy, how it works, and where it may fit into clinical practice. From innovation to real-world application, this conversation highlights what providers should know as new technologies continue to shape the future of patient care. Contact us by calling (800) 399-6565 or visitin...

Episode thumbnail for From ASCRS 2026: iDose TR & Interventional Glaucoma (IG) (Part 2) – Featuring Glaukos

April 27, 2026

From ASCRS 2026: iDose TR & Interventional Glaucoma (IG) (Part 2) – Featuring Glaukos

In Part 2 of our ASCRS 2026 coverage, we dive into iDose TR and the evolution of interventional glaucoma. Joined by Tom Powell and Cynthia Pointer from Glaukos, we explore what these innovations mean in practice, how they’re changing treatment approaches, and what providers should be paying attention to moving forward. Contact us by calling (800) 399-6565 or visiting CorcoranCCG.

11 total episodes available

Deep-dive analytics for Ophthalmology Reimbursed

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is Ophthalmology Reimbursed?
<p>Ophthalmology Reimbursed discusses all things coding, reimbursement, auditing and education for the ophthalmic community. Since 1986, Corcoran Consulting Group has served thousands of physicians in ophthalmic and optometric practices in all 50 states.</p>
How often does this podcast release new episodes?

This podcast updates daily.

Where can I listen to this podcast?

This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.